Matthew Oberley, Chief Clinical Officer Caris Life Sciences, shared a post on LinkedIn:
“Our recent study describing improved diagnosis through AI is nicely highlighted by the linked article; it is just the tip of the iceberg.
We are working on additional studies describing the opportunity to help improve diagnosis in the realm of Breast Cancer, in Mesothelioma, and with Hematologic Malignancies. Ultimately our goal is to show improved outcomes are possible through the intelligent use of these tools”
Other articles about Matthew Oberley on OncoDaily.